Theriva Biologics, Inc. (TOVX) AMEX
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.55M |
| Enterprise Value | -7.87M |
| P/E Ratio | -0.64 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 24.48 |
| Price/Book Ratio | 0.68 |
| Enterprise/Revenue | 2.23 |
| Enterprise/EBITDA | -0.08 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -29.09 |
| Operating Margin | -29.98 |
| Return On Assets | -0.28 |
| Return On Equity | -0.65 |
| Revenue | 0 |
| Revenue/Share | 0.01 |
| Gross Profit | -108,000 |
| EBITDA | -23.63M |
| Net Income | -25.25M |
| Diluted EPS | -2.08 |
| Total Cash | 8.47M |
| Total Cash/Share | 0.18 |
| Total Debt | 3.43M |
| Total Debt/Equity | 0.17 |
| Current Ratio | 1.21 |
| Book Value Per Share | 0.23 |
| 52-Week Change | -46.31 |
| 52-Week High | 0.49 |
| 52-Week Low | 0.14 |
| Moving Average 50 Days | 0.21 |
| Moving Average 200 Days | 0.24 |
| Average Volume | 2M |
| Shares Outstanding | 45.89M |
| % Held by Institutions | 4.32 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | August 26, 2024 |